The estimated Net Worth of John N Varela is at least $820 Tisíc dollars as of 11 August 2017. Mr. Varela owns over 12,000 units of RTI Surgical stock worth over $150,714 and over the last 10 years he sold RTIX stock worth over $0. In addition, he makes $669,364 as Executive Vice President - Global Operations at RTI Surgical.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Varela RTIX stock SEC Form 4 insiders trading
John has made over 1 trades of the RTI Surgical stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 12,000 units of RTIX stock worth $58,200 on 11 August 2017.
The largest trade he's ever made was buying 12,000 units of RTI Surgical stock on 11 August 2017 worth over $58,200. On average, John trades about 1,000 units every 0 days since 2015. As of 11 August 2017 he still owns at least 47,998 units of RTI Surgical stock.
You can see the complete history of Mr. Varela stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Varela biography
John Varela is Executive Vice President - Global Operations of the Company. He was named Executive Vice President, Global Operations in January 2017. Mr. Varela joined RTI in July 2014 as Vice President, U.S. Operations to oversee all aspects of U.S. manufacturing and distribution. In December 2014, he assumed additional responsibilities to oversee information technology, including SAP, and became an executive officer effective January 1, 2015. Prior to joining RTI, Mr. Varela was the Director of Operations for Heraeus Electro-Nite, Inc. (a company involved in the measurement, monitoring and control of molten metals) from September 2011 to July 2014. Before joining RTI, Mr. Varela had more than twelve years of experience in the medical device industry with such companies as Teleflex Medical from 2004 to 2008 and Accellent, Inc. from 2008 to 2011. In his role at Accellent, Mr. Varela served as Director of Operations implementing lean principles to transform manufacturing flow and improve delivery performance. Mr. Varela spent the early part of his career with General Electric and Phillips Lighting Company. He has over thirty years of experience in various leadership positions within manufacturing and supply chain industries. Mr. Varela earned a bachelor’s degree in mechanical engineering from The Pennsylvania State University and a master’s degree in environmental engineering from Drexel University. He has also earned his Six Sigma Master Black Belt and is certified in Production and Inventory Management.
What is the salary of John Varela?
As the Executive Vice President - Global Operations of RTI Surgical, the total compensation of John Varela at RTI Surgical is $669,364. There are 1 executives at RTI Surgical getting paid more, with Jonathon Singer having the highest compensation of $2,188,310.
How old is John Varela?
John Varela is 52, he's been the Executive Vice President - Global Operations of RTI Surgical since 2017. There are 7 older and 3 younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.
What's John Varela's mailing address?
John's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, DEERFIELD, IL, 60015.
Insiders trading at RTI Surgical
Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper a Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.
What does RTI Surgical do?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
What does RTI Surgical's logo look like?
Complete history of Mr. Varela stock trades at RTI Surgical
RTI Surgical executives and stock owners
RTI Surgical executives and other stock owners filed with the SEC include:
-
Jonathon Singer,
Chief Financial Officer, Chief Operating Officer -
John Varela,
Executive Vice President - Global Operations -
Olivier Visa,
Vice President - OEM, Sports and Donor Services -
Shirley Weis,
Independent Director -
Thomas McEachin,
Independent Director -
Mark Stolper,
Lead Independent Director -
Paul Thomas,
Independent Director -
Nicholas Valeriani,
Independent Director -
Pawel Lewicki,
Director -
Scott Durall,
Chief Commercial Officer -
Bryan Cornwall,
Executive Vice President - Research and Clinical Affairs -
Stuart Simpson,
Chairman of the Board -
Molly Poarch,
Director, Corporate Communications & Investor Relations -
Jeffrey Lightcap,
Independent Director -
Brian Kushner,
Director -
Ryan Bartolucci,
Vice President - Finance, Corporate Controller -
Terry Rich,
President, Chief Executive Officer, Director -
Lyle P. Luedeman,
-
Dean H Bergy,
Director -
Street Healthcare Partners ...,
-
Christopher R Sweeney,
Director -
Curtis M Selquist,
Director -
Peter F Gearen,
Director -
Brian K Hutchison,
Chairman, President and CEO -
Camille Farhat,
Chief Executive Officer -
Robert P Jordheim,
Executive Vice President/CFO -
Roger W Rose,
Vice President Donor Services -
Johannes Wynand Louw,
Vice President Finance -
Kevin D Brandt,
EVP CCO-Domestic Direct -
Joshua H De Rienzis,
General Counsel -
Philip R Chapman,
Director -
Ned Hoye Villers,
Director -
Adrian J R Smith,
Director -
Caroline A Hartill,
V.P. Quality Assurance -
Julianne M Bowler,
Director -
Roy D Crowninshield,
Director -
Gregory P Rainey,
Director -
Neal B Freeman,
Director -
Michael J La Prade,
Vice President -
Holdings Inc Zimmer,
10% owner -
Roderick N Allen,
Vice President -
David J Simpson,
Director -
Guy L Mayer,
President -
Michael J Odrich,
Director -
Lee Robert Jr Johnston,
Vice President -
Udo Henseler,
Director -
Christie J Blakely,
Vice President -
Robert J Lane,
Vice President -
Tara Leigh Zerby,
VP, Xenograft Technologies -
Carolyn Shaffer,
Vice President, Human Resource -
Thomas F Rose,
Vice President and CFO -
Michael T Manley,
Director -
Louis E Barnes,
Vice President-Cardiovascular -
Charles Randal Mills,
V.P. of Business Development -
William Melendez,
Vice President, Research & Dev -
Jeffrey Michael Schumm,
Vice Pres. and General Counsel -
Joseph W Condon,
Vice President-Operations